PEDEvidence

SOURCE-LINKED STUDY SUMMARY

MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.

The Journal of clinical endocrinology and metabolism ·

Human

Abstract summarizedQuality not appraised
What was studied
A randomized crossover study tested whether MK-677 could reverse negative nitrogen balance during calorie restriction.
Who / model studied
Eight healthy adults aged 24–39 years completed two calorie-restricted study periods.
Studied dose & schedule
During the final seven days of each 14-day diet period, participants received oral MK-677 25 mg or placebo once daily, separated by a 14–21-day washout.
What the study found
Daily nitrogen balance was +0.31 g/day with MK-677 versus −1.48 g/day with placebo. IGF-I also rose. The dose was generally well tolerated without clinically significant adverse experiences.
Limitations & context
This was an eight-person, seven-day exposure. Nitrogen balance is not direct evidence of preserved muscle size, strength, or long-term outcomes during dieting.

Read summary source ↗ · Prepared 10/6/2026 · AI-assisted, source-based summary

Review record & corrections

Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.

No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.

Inspect the source · Correction policy

Save, annotate or compare this study in the library →

Research findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.

Original publication ↗ · DOI: 10.1210/jcem.83.2.4551

Explore related compounds

Evidence and review standards

← All study summaries